新和成（002001）：结构升级，韧性十足：新和成（002001.SZ）

Investment Rating - The investment rating for the company is "Buy" (首次) [5] Core Views - The company demonstrates strong resilience and structural upgrades, with a significant growth forecast in revenue and profit [5][6] - The company has a diversified product line, with notable growth in methionine, flavors, and new materials, which has contributed to its historical high profits despite declining vitamin prices [6] - The company is positioned as a global leader in fine chemicals, with strong pricing power and growth potential in new materials [6] Financial Performance Summary - Revenue projections for the company are as follows: - 2023: 15,117 million RMB - 2024: 21,610 million RMB (42.95% YoY growth) - 2025: 22,518 million RMB (4.20% YoY growth) - 2026: 24,137 million RMB (7.19% YoY growth) - 2027: 27,161 million RMB (12.53% YoY growth) [5] - Net profit forecasts are: - 2023: 2,704 million RMB - 2024: 5,869 million RMB (117.01% YoY growth) - 2025: 6,764 million RMB (15.25% YoY growth) - 2026: 7,088 million RMB (4.79% YoY growth) - 2027: 7,715 million RMB (8.85% YoY growth) [5] - Earnings per share (EPS) are projected to increase from 0.88 RMB in 2023 to 2.51 RMB in 2027 [5] Market Position and Product Insights - The company has a strong cost advantage in methionine production, with a capacity of 550,000 tons, ranking among the top globally [6] - The flavor segment shows robust profitability, with a consistent revenue growth of over 10% since 2021 and an increase in gross margin from 42% in 2021 to 54% in the first half of 2025 [6] - New materials, particularly specialty engineering plastics, are expected to grow rapidly, with significant revenue increases projected for 2024 and 2025 [6] Valuation Metrics - The projected price-to-earnings (P/E) ratios are as follows: - 2024: 15.50 - 2025: 13.45 - 2026: 12.83 - 2027: 11.79 [5][8] - The company is compared with peers such as Andisoo, Zhejiang Medicine, and Jindawei, highlighting its competitive position in the fine chemicals sector [6]